Most individuals with CDLS have either a heterozygous pathogenic variant in NIPBL, RAD21, or SMC3 or a hemizygous pathogenic variant in HDAC8 or SMC1A. The most prevalent mutations are in the NIPBL gene, found in 60–70% of affected individuals. The gene discussed is RAD21; the disease is Cornelia de Lange syndrome.